Clinical Trial Update: A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 study evaluated IMU-131 (HER-Vaxx) in combination with chemotherapy versus chemotherapy alone in HER2-positive advanced gastric cancer; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• IMU-131 (HER-Vaxx) (IMU-131)

Snippet

Sponsor: Imugene Limited | Conditions: Gastrointestinal Neoplasms, Adenocarcinoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-16